Impact of the FDS Approval of Adalimumab on the Management of Uveitis

Authors

Andrea McCullum Mejia, HCA HealthcareFollow
Adam Grunbaum, HCA HealthcareFollow
Daniel Rodney
Grace Levy-Clarke, HCA HealthcareFollow

Preview

Division

West Florida

Hospital

Regional Medical Center Bayonet Point

Specialty

Rheumatology

Document Type

Image

Publication Date

2021

Keywords

uveitis, adalimumab, inflammation

Disciplines

Eye Diseases | Ophthalmology | Rheumatology | Therapeutics

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

McCullum Mejia, Andrea; Grunbaum, Adam; Rodney, Daniel; and Levy-Clarke, Grace, "Impact of the FDS Approval of Adalimumab on the Management of Uveitis" (2021). West Florida Division GME Research Day 2021. 40.
https://scholarlycommons.hcahealthcare.com/westflorida2021/40